1-20 of 27
Sort by
News

10 Years as a PA: Reflecting on Education Amid a Clinical Site Shortage

Published: 2024
Abstract
Mid-July 2024
View News titled, 10 Years as a PA: Reflecting on Education Amid a Clinical Site Shortage
News

Straight-to-Transplantation Approach Comparable to Remission Induction in Difficult Acute Myeloid Leukemia Cases

Thomas R. Collins
Published: 2024
Abstract
Mid-July 2024
View News titled, Straight-to-Transplantation Approach Comparable to Remission Induction in Difficult Acute Myeloid Leukemia Cases
News

Oral Drug Effective for Rare WHIM Syndrome, Approved by FDA

Anna Azvolinsky, PhD
Published: 2024
Abstract
Mid-July 2024
View News titled, Oral Drug Effective for Rare WHIM Syndrome, Approved by FDA
News

Mosunetuzumab Therapy Elicits High, Durable Responses in Patients With Follicular Lymphoma

Anna Azvolinsky, PhD
Published: 2024
Abstract
Mid-July 2024
View News titled, Mosunetuzumab Therapy Elicits High, Durable Responses in Patients With Follicular Lymphoma
News

Understanding the Prognostic Impact of TP53 Mutations in Chronic Lymphocytic Leukemia

Lara C. Pullen, PhD
Published: 2024
Abstract
Mid-July 2024
View News titled, Understanding the Prognostic Impact of TP53 Mutations in Chronic Lymphocytic Leukemia
News

ATRA-ATO Regimen Demonstrates Superior EFS in Newly Diagnosed, High-Risk Acute Promyelocytic Leukemia

Khylia Marshall
Published: 2024
Abstract
Mid-July 2024
View News titled, ATRA-ATO Regimen Demonstrates Superior EFS in Newly Diagnosed, High-Risk Acute Promyelocytic Leukemia
News

Phase II CAPTIVATE Study: The 5.5-Year Update

Lara C. Pullen, PhD
Published: 2024
Abstract
Mid-July 2024
View News titled, Phase II CAPTIVATE Study: The 5.5-Year Update
News

Venetoclax May Increase Toxicity But Not Efficacy When Added to R-CHOP in Double-Expressor DLBCL

Katie Robinson
Published: 2024
Abstract
Mid-July 2024
View News titled, Venetoclax May Increase Toxicity But Not Efficacy When Added to R-CHOP in Double-Expressor DLBCL
News

Safety of Oral Azacytidine in Patients With Lower-Risk MDS Consistent With Prior Results

Anna Azvolinsky, PhD
Published: 2024
Abstract
Mid-July 2024
View News titled, Safety of Oral Azacytidine in Patients With Lower-Risk MDS Consistent With Prior Results
News

Mid-July 2024 Data Stream

Published: 2024
Abstract
Mid-July 2024
View News titled, Mid-July 2024 Data Stream
News

Study Identifies Characteristics Related to Bispecific Antibody Response, Resistance

Leah Lawrence
Published: 2024
Abstract
Mid-July 2024
View News titled, Study Identifies Characteristics Related to Bispecific Antibody Response, Resistance
News

Addition of Avatrombopag to Cyclosporine Can Improve Response Rate in Elderly Patients with Transfusion-Dependent, Non-Severe Aplastic Anemia

Anna Azvolinsky, PhD
Published: 2024
Abstract
Mid-July 2024
View News titled, Addition of Avatrombopag to Cyclosporine Can Improve Response Rate in Elderly Patients with Transfusion-Dependent, Non-Severe Aplastic Anemia
News

Patients With Functional High-Risk Multiple Myeloma Show High Response With Ide-Cel

Lara C. Pullen, PhD
Published: 2024
Abstract
Mid-July 2024
View News titled, Patients With Functional High-Risk Multiple Myeloma Show High Response With Ide-Cel
News

Adenine Base Editors Could Offer Alternative Approach in Beta Hemoglobinopathies Gene Therapies

Ruth Jessen Hickman, MD
Published: 2024
Abstract
Mid-July 2024
View News titled, Adenine Base Editors Could Offer Alternative Approach in Beta Hemoglobinopathies Gene Therapies
News

Quad Regimen Reduces Risk of Progression, Death in Older Patients with NDMM

Khylia Marshall
Published: 2024
Abstract
Mid-July 2024
View News titled, Quad Regimen Reduces Risk of Progression, Death in Older Patients with NDMM
News

Survival Benefit Remains Unclear for Upfront AlloHCT in Untreated Aggressive ATL

Katie Robinson
Published: 2024
Abstract
Mid-July 2024
View News titled, Survival Benefit Remains Unclear for Upfront AlloHCT in Untreated Aggressive ATL
News

Fewer Patients With CLL/SLL Switch From Zanubrutinib to Another BTKi

Ruth Jessen Hickman, MD
Published: 2024
Abstract
Mid-July 2024
View News titled, Fewer Patients With CLL/SLL Switch From Zanubrutinib to Another BTKi
News

Teclistamab Combination with Daratumumab, Lenalidomide Shows Promising Efficacy, Tolerability in Patients with NDMM

Anna Azvolinsky, PhD
Published: 2024
Abstract
Mid-July 2024
View News titled, Teclistamab Combination with Daratumumab, Lenalidomide Shows Promising Efficacy, Tolerability in Patients with NDMM
News

Rituximab Maintenance in MCL Found Advantageous After Firstline Treatment With Bendamustine-Rituximab

Thomas R. Collins
Published: 2024
Abstract
Mid-July 2024
View News titled, Rituximab Maintenance in MCL Found Advantageous After Firstline Treatment With Bendamustine-Rituximab
News

CARTITUDE-2 Cohort D: Cilta-Cel ± Len Effective for Multiple Myeloma

Lara C. Pullen, PhD
Published: 2024
Abstract
Mid-July 2024
View News titled, CARTITUDE-2 Cohort D: Cilta-Cel ± Len Effective for Multiple Myeloma